Condition
Aspirin-Sensitive Asthma With Nasal Polyps
Total Trials
5
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Unknown2
Completed1
Active Not Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05575037Phase 2Active Not Recruiting
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
NCT03326063Phase 2Completed
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
NCT03973749Not ApplicableUnknown
Effects of a High or Low Salycilate Diet on Urinary LTE4 and Clinical Features in AERD
NCT03441438Not ApplicableUnknownPrimary
Mechanisms of Alcohol Sensitivity in AERD
NCT01615536Not ApplicableWithdrawn
The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus
Showing all 5 trials